Combating the Opioid Crisis

Excerpt: “Each calendar year, the DEA sets the aggregate production quota (APQ) of controlled substances, including opioids, to ensure that patients have the medicines they need while also reducing excess production of controlled prescription drugs that can be diverted and misused,” wrote Walden, Guthrie, Burgess, and Griffith.

Click HERE to read the letter to DEA.

Washington, D.C. - Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Representative Morgan Griffith (R-VA) sent a letter to Food and Drug Administration (FDA) Commissioner Stephen Hahn, M.D., to request information on the FDA approval of a OxyContin label change in 2001.

The inquiry follows a briefing FDA provided at the request of bipartisan E&C leaders, in which the FDA presented information they believed showed the opioid crisis was not exacerbated by their decision to approve the change...